XML 25 R14.htm IDEA: XBRL DOCUMENT
v3.23.4

CUSTOMER CONCENTRATIONS AND FOREIGN SALES | 9 Months Ended
--- | ---
Nov. 30, 2023
Risks and Uncertainties [Abstract] |
CUSTOMER CONCENTRATIONS AND FOREIGN SALES | NOTE 8: CUSTOMER CONCENTRATIONS AND FOREIGN SALES Export sales to customers located outside the United States and Canada were approximately as follows: Schedule of Customer Concentrations and Foreign Sales
|  | Nine Months Ended November 30, |  |  | Three Months Ended November 30, |
|  | 2023 |  |  | 2022 |  |  | 2023 |  |  | 2022 |
Asia Pacific (APAC) |  | $ | 1,790,000 |  |  | $ | 2,367,000 |  |  | $ | 681,000 |  |  | $ | 834,000 |
Europe, Middle East, Asia (EMEA) |  |  | 3,057,000 |  |  |  | 2,557,000 |  |  |  | 1,476,000 |  |  |  | 731,000 |
Latin America |  |  | 1,097,000 |  |  |  | 1,301,000 |  |  |  | 112,000 |  |  |  | 436,000 |
|  | $ | 5,944,000 |  |  | $ | 6,225,000 |  |  | $ | 2,269,000 |  |  | $ | 2,001,000 |
In the first nine months of fiscal 2024 and fiscal 2023, sales to foreign customers accounted for approximately $5,944,000 and $6,225,000, or 40% and 55%, respectively, of total revenues. During the third quarter of fiscal 2024 and fiscal 2023, sales to foreign customers accounted for approximately $2,269,000 and $2,001,000, or 40% and 56%, respectively, of total revenues. The Company had no customers that accounted for more than 10% of sales during the first nine months of fiscal 2024. The Company had one customer which accounted for 13% of sales during the third quarter of fiscal 2024. One customer accounted for 25% of the outstanding accounts receivables at November 30, 2023. The Company had two customers which accounted for 14% of sales during the first nine months of fiscal 2023. The Company had two customers which accounted for 21% of sales during the third quarter of fiscal 2023. Four customers accounted for 44% of the outstanding accounts receivable at February 28, 2023.

X
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 275 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//275/tableOfContent + Details
Name: | us-gaap_ConcentrationRiskDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RisksAndUncertaintiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration